IAM is universally acknowledged as the world’s leading IP business information provider. IAM was launched in July 2003 to address the need for organizations to maximize the value of their intellectual property and other intangibles, and to examine the strategies that they can put in place to do this. IAM is unique because it treats intellectual property as a business asset and tool, rather than simply as a legal right. With this unequalled appeal to the boardroom, IAM has firmly established itself as the only IP publication that many senior corporate executives read regularly.
Click here for further information on other IAM events.
With disruptive political and legislative change on the horizon at home and abroad, it has never been more important for European biopharma patent professionals to have a crystal-clear understanding of the changes shaping IP protection and value creation.
IAM’s third annual Pharma & Biotech IP event will provide cutting-edge legal and strategic insights to help practitioners safeguard and exploit their crucial life sciences assets.
Registrations / general enquiries
T +44 20 7939 4011
Additional ticket sales
T +44 20 7939 4263
T +44 20 7940 6862